Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01613651 · ClinicalTrials.gov registry record · Phase 3
Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer
A Phase 3 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 191
- Enrollment target
NCT01613651 is a Phase 3 study that has completed, run by City of Hope Medical Center. The registered enrollment target is 191 participants.
The verdict
NCT01613651, a Phase 3 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 191 participants
- Enrollment target
Study Summary
This randomized phase III trial studies robotic assisted laparoscopic prostatectomy (RALP) with pelvic drain placement to see how well it works compared to RALP without pelvic drain replacement in reducing adverse events after surgery in patients with prostate cancer.
Interventions
- OTHER questionnaire administration
- PROCEDURE robot-assisted laparoscopic surgery
- OTHER intraoperative complication management/prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 191 participants |
| Start Date | 2012-08-24 |
| Est. Completion | 2017-09-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01613651
The ClinicalTrials.gov registry entry for NCT01613651 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 191 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01613651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01613651 about?
NCT01613651 is a clinical study titled "Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer". This randomized phase III trial studies robotic assisted laparoscopic prostatectomy (RALP) with pelvic drain placement to see how well it works compared to RALP without pelvic drain replacement in reducing adverse events after surgery in patients with prostate cancer.
What is the current status of trial NCT01613651?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 191 participants. The study started on 2012-08-24. Estimated completion is 2017-09-11.
What interventions are being tested in trial NCT01613651?
The interventions under investigation include: questionnaire administration (OTHER), robot-assisted laparoscopic surgery (PROCEDURE), intraoperative complication management/prevention (OTHER).
Who is sponsoring clinical trial NCT01613651?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.